Impact of a biomarker-based strategy on oncology drug development: A meta-analysis of clinical trials leading to FDA approval
Denis L.Fontes Jardim, Maria Schwaederle, Caimiao Wei, J. Jack Lee, David S. Hong, Alexander M. Eggermont, Richard L. Schilsky, John Mendelsohn, Vladimir Lazar, Razelle Kurzrock
Research output: Contribution to journal › Review article › peer-review
159Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Impact of a biomarker-based strategy on oncology drug development: A meta-analysis of clinical trials leading to FDA approval'. Together they form a unique fingerprint.